Prevalence of metastases in hepatocellular carcinoma: Risk factors and impact on survival

American Surgeon

Volumn 69, Issue 10, 2003, Pages 879-885

  Si, Ming Sing ^a   Amersi, Farin ^b   Golish, S Raymond ^c   Ortiz, Jorge A ^a,d   Zaky, Joseph ^b   Finklestein, Debbie ^b   Busuttil, Ronald W ^b   Imagawa, David K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCLA MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d ALBERT EINSTEIN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL TUMOR; ARTICLE; BONE TUMOR; CASE CONTROL STUDY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PREVALENCE; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL; SURVIVAL; THORAX TUMOR; TIME; WEIGHT REDUCTION;

ABDOMINAL NEOPLASMS; BONE NEOPLASMS; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FEMALE; HUMANS; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; THORACIC NEOPLASMS; TIME FACTORS; WEIGHT LOSS;

EID: 0242285651     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)

1. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745-750 (Pubitemid 29114292)
2. Rogiers X, Brunken C, Malago M, et al. Surgical therapy of hepatocellular carcinoma. Digestion 1998;59(suppl 2):78-79
3. Olthoff KM. Surgical options for hepatocellular carcinoma: resection and transplantation. Liver Transpl Surg 1998;5(suppl 1):S98-104.
4. Kaczynski J, Hansson G, Wallerstedt S. Metastases in cases with hepatocellular carcinoma in relation to clinicopathologic features of the tumor. An autopsy study from a low endemic area. Acta Oncol 1995;34:43-48
5. Hosmer DW, Lemeshow S. Confidence interval estimates of an index of quality performance based on logistic regression models. Stat Med 1995;14:2161-2172
6. Lee YT, Geer DA. Primary liver cancer: pattern of metastasis. J Surg Oncol 1987;36:26-31. (Pubitemid 17139540)
7. Musso O, Théret N, Campion JP, et al. In situ detection of matrix metalloproteinase-2 (MMP2) and the metalloproteinase inhibitor TIMP2 transcripts in human primary hepatocellular carcinoma and in liver metastasis. Hepatol 1997;26:593-605.
8. Hayasaka A, Suzuki N, Fujimoto N, et al. Elevated plasma levels of matrix metalloproteinase-9 (92-kd type IV collagenase/gelatinase B) in hepatocellular carcinoma. Hepatology 1996;24:1058-1062 (Pubitemid 26365903)
9. Piccinino F, Sagnelli E, Pasquale G, et al. Complications following percutaneous liver biopsy. A multicenter retrospective study on 68,276 biopsies. J Hepatol 1986;2:165-173 (Pubitemid 16125908)
10. Froehlich F, Lamy O, Fried M, et al. Practice and complications of liver biopsy. Results of a nationwide survey in Switzerland. Dig Dis Sci 1993;38:1480-1484
11. Schotman SN, De Man RA, Stoker J, et al. Subcutaneous seeding of hepatocellular carcinoma after percutaneous needle biopsy. Gut 1999;45:6260-6267 (Pubitemid 29447837)
12. Soyer P, Pelage JP, Dufresne AC, et al. CT of abdominal wall implantation metastases after abdominal percutaneous procedures. J Comput Assist Tomogr 1998;22:889-893 (Pubitemid 28533571)
13. Takamori R, Wong LL, Dang C, et al. Needle tract implantation from hepatocellular cancer: is needle biopsy of the liver always necessary? Liver Transpl 2000;6:67-72.
14. Maeda M, Koyama W, Sato C, et al. Hepatocellular carcinoma producing universal type of alkaline phosphatase. Dig Dis Sci 1993;38:757-761
15. Bukofzer S, Kew MC, Rowe P. The prevalence of variant alkaline phosphatase in hepatocellular carcinoma in southern African blacks. Cancer 1988;62:978-981 (Pubitemid 18231500)
16. Mayne PD, Thakrar S, Rosalki SB, et al. Identification of bone and liver metastases from breast cancer by measurement of plasma alkaline phosphatase isoenzyme activity. J Clin Pathol 1987;40:398-403. (Pubitemid 17046180)
17. Withold W, Georgescu G, Khakzad H, et al. Efficacy of simultaneous determination of bone alkaline phosphatase mass concentration in serum and urinary excretion of pyridinium crosslinks for detection of bone metastases. Clin Biochem 1995;28:511-519
18. Yen TC, Hwang SJ, Wang CC, et al. Hypercalcemia and parathyroid hormone-related protein in hepatocellular carcinoma. Liver 1993;13:311-315 (Pubitemid 24037117)
19. Chu CW, Hwang SJ, Luo JC, et al. Manifestations of hypercholesterolemia, hypoglycemia, erythrocytosis and hypercalcemia in patients with hepatocellular carcinoma: report of two cases. J Gastroenterol Hepatol 1999;14:807-810